仙琚制药：公司已于2025年4月制定并公告了市值管理制度

Group 1 - The company has established a market value management system as of April 2025 [2] - The responsibility for market value management lies with the board of directors, with participation from the management team [2] - Further details can be found in the relevant announcements [2]